Bladder cancer combo shows promise in Real-World review
Knowledge-focused
Not yet recruiting
This study looks back at how well a combination of two drugs—enfortumab vedotin and pembrolizumab—works as the first treatment for people with advanced bladder cancer that has spread. Researchers will collect data from 361 patients around the world to see how long they live and h…
Sponsor: Aron Research Foundation Ets • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC